QAS.AI (NSF-2304388) is using artificial intelligence (AI) to help neurosurgeons to treat brain aneurysms in real-time. The company’s technology detects areas of inadequate blood flow in the brain during surgery and predicts the efficacy of aneurysm correction six months after embolization. Article via UBNow